Corcoran v. Boston Scientific

CourtDistrict Court, W.D. New York
DecidedFebruary 16, 2022
Docket1:20-cv-00603
StatusUnknown

This text of Corcoran v. Boston Scientific (Corcoran v. Boston Scientific) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Corcoran v. Boston Scientific, (W.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

PAMELA CORCORAN, Plaintiff, v. DECISION AND ORDER 20-CV-603S BOSTON SCIENTIFIC, Defendant.

I. Introduction This is an employment action where Plaintiff, Pamela Corcoran, alleges her former employer, Boston Scientific, violated Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e-2000e-17 (“Title VII”), for sex discrimination and retaliation; the Americans with Disabilities Act, 42 U.S.C. § 121132 (“ADA”), for disability discrimination and retaliation; and the Equal Pay Act, 29 U.S.C. § 206(d). Plaintiff claims Defendant reassigned her from a lucrative sales region due to her sex and in retaliation for her past complaints, reducing her salary as a result. Presently before this Court is Defendant’s Motion to Dismiss or alternatively for Summary Judgment (Docket No. 5). As a Summary Judgment Motion, Boston Scientific argues Plaintiff’s claims are time barred while contending in its Motion to Dismiss that Plaintiff generally fails to state a claim. For the reasons stated below, Defendant’s Motion (Docket No. 5) is converted into a Motion for Partial Summary Judgment. As such, that Motion is granted in part and the claims deemed untimely herein are dismissed. Plaintiff’s Title VII discrimination and retaliation claims for alleged events before January 7, 2019, are time barred. All her ADA discrimination and retaliation claims before that date also are barred. Plaintiff’s Equal Pay claims for paychecks from May 21, 2018, are timely, but claims before this date are time barred. Defendant’s alternative Motion to Dismiss (id.) the remaining timely claims is

granted in part (dismissing her Equal Pay Act claims) and denied in part (allowing her sex discrimination and retaliation claims under Title VII to proceed). Following adjudication of this Motion, the remaining claims of sex discrimination and retaliation under Title VII arising after January 7, 2019, in the Complaint are discernable without requiring amended pleading. Defendant thus shall have fourteen (14) days from entry of this Decision and Order to file an Answer to these surviving claims and the case will be referred to a Magistrate Judge for further pretrial proceedings. II. Background A. Facts The facts in this record are not contested and the parties’ versions are consistent

(see Docket No. 1, Compl.; Docket No. 5, Def.’s Statement of Material Facts). Given this consistency and absent objection, this Court will cite to the Complaint (Docket No. 1), Defendant’s Statement of Material Facts (Docket No. 5), and, where applicable for the Motion for Partial Summary Judgment, Defendant’s uncontested sworn statements submitted in support of its Motion (Docket No. 5). Defendant employed Plaintiff as a business partner in the northeastern region of Defendant’s Interventional Cardiology division (Docket No. 1, Compl., First Cause of Action, Additional Evidence of Sex Discrimination ¶ 16; Docket No. 5, Def. Atty. Decl. Ex. A (Plaintiff’s Attorney’s letter, Mar. 20, 2019)). She later developed a stress-induced disability (Docket No. 1, Compl. at 2, Factual Background, ¶ 10). Plaintiff remained with Defendant until she resigned sometime in August 2019 (Docket No. 5, Def. Statement ¶ 1; Docket No. 5, Prust Decl. ¶ 7). Defendant termed her resignation voluntary (Docket No. 5, Def. Statement ¶ 1; Docket No. 5, Prust Decl. ¶ 7).

During her tenure, Defendant tied Plaintiff’s salary to revenue generated from her assigned sales region. Her assigned region generated $22 million in annual revenue, earning Plaintiff an annual salary of $375,000. (Docket No. 1, Compl. at 3, First Cause of Action, Element 2, ¶¶ 3, 4; see Docket No. 5, Def. Statement ¶ 6.) Plaintiff was the only female business partner in her assigned region. She also observed that, in 2017, only five of 38 Defendant’s business partners were women, but, in 2018-19, seven of 56 partners were women. (Docket No. 1, Compl., First Cause of Action, at 4-5, Additional Evidence of Sex Discrimination ¶¶ 16-18.) After Plaintiff complained about being discriminated against, she alleges that Defendant assigned her to a different sales territory (Docket No. 5, Def. Statement ¶¶ 2-

6). The new territory generated only $11 million in annual revenue (id. ¶¶ 4, 6; Docket No. 1, Compl., First Cause of Action at 4, Element 2, ¶ 5). Plaintiff’s reassignment reduced her salary to approximately $250,000 per year (Docket No. 1, Compl., First Cause of Action, at 4, Element 2, ¶ 6). Meanwhile, Defendant allegedly compensated her male replacement with an annual salary greater than $375,000, more than she earned (id., First Cause of Action, at 4-5, Additional Evidence of Sex Discrimination, ¶¶ 19-20, First Cause of Action, at 4, Element 2, ¶ 7). Defendant contends that Plaintiff’s reassignment was part of a company-wide realignment and Plaintiff’s new territory annually generated $13 million (Docket No. 5, Def. Statement ¶ 6). Defendant denies Plaintiff’s sales quota dropped below $6 million, contrary to her allegations (id. ¶ 11; Docket No. 5, Prust Decl. ¶ 6; see Docket No. 5, Def. Memo. at 6; but cf. Docket No. 1, Compl. Second Cause of Action, Element 2, Adverse Action ¶ 32, Third Cause of Action, Element 2, Adverse Action ¶ 51).

Following her departure in 2019, Plaintiff alleges that Defendant demanded that she repay it “multiple thousands of dollars” (Docket No. 1, Compl., First Cause of Action, at 4, Element 2, Adverse Actions, ¶ 8, Second Cause of Action, at 6, Element 2, Adverse Actions, ¶ 33, Third Cause of Action, at 8, Element 2, Adverse Actions, ¶ 52). On September 16, 2019, Defendant’s HR Service Center noted Plaintiff was overpaid for a leave of absence she took in April 2019. Defendant paid Plaintiff at a regular work rate while she was in fact on leave for 72 hours. Defendant asked Plaintiff to remit $1,952.72 overpayment and she did so. (Docket No. 5, Def. Statement ¶¶ 12, 13.) Meanwhile, Plaintiff claims she exhausted her administrative remedies and filed a charge of discrimination on November 1, 2019, with the Equal Employment Opportunity

Commission (“EEOC”) and subsequently received a Right to Sue letter (Docket No. 1, Compl., at 2, ¶¶ 5-7). Defendant contends that it did not receive this initial charge, but it eventually received an EEOC charge from Plaintiff dated December 5, 2019 (Docket No. 5, Def. Memo. at 7, 21 n.10; id., Def. Atty. Decl. ¶¶ 3-4, Ex. C). Defendant’s exhibit of the initial EEOC charge is dated November 7, 2019 (Docket No. 5, Def. Atty. Decl. ¶ 3, Ex. B). B. Complaint In the First Cause of Action, Plaintiff alleges sex discrimination because of the retaliatory reassignment of her sales territory (Docket No. 1, Compl., First Cause of Action, at 3-5). She also claims that, when she applied for her original position with Defendant, an unnamed male superior told her that she should not work but instead should be at home with her son (id., First Cause of Action, at 4, Additional Evidence of Sex Discrimination ¶ 14). Upon her information and belief, Plaintiff contends that the

wives of the male colleagues stayed home and did not work outside of the home (id. ¶ 15). The record does not disclose when this interview episode occurred. In the Second Cause of Action, Plaintiff alleges her reassignment was an adverse action under the ADA based upon her stress-induced disability (id., Second Cause of Action, at 6, Element 2, Adverse Action ¶¶ 26-33; see id. ¶ 10). Plaintiff claims that “her disability is demonstrated by her request to take multiple medical leaves due to stress at work” (id. ¶ 25).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Corning Glass Works v. Brennan
417 U.S. 188 (Supreme Court, 1974)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
County of Washington v. Gunther
452 U.S. 161 (Supreme Court, 1981)
Trans World Airlines, Inc. v. Thurston
469 U.S. 111 (Supreme Court, 1985)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Robinson v. Shell Oil Co.
519 U.S. 337 (Supreme Court, 1997)
Burlington Industries, Inc. v. Ellerth
524 U.S. 742 (Supreme Court, 1998)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Ledbetter v. Goodyear Tire & Rubber Co., Inc.
550 U.S. 618 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Corcoran v. Boston Scientific, Counsel Stack Legal Research, https://law.counselstack.com/opinion/corcoran-v-boston-scientific-nywd-2022.